Indeed, clinicians were concerned by the increased prevalence of tuberculosis in patients receiving TNF inhibitors, and particularly by the noticeable emergence of extra-pulmonary/disseminated and rapidly progressive tuberculosis [23]. The gene discussed is TNF; the disease is tuberculosis.